Contribution of the Ambulatory Measure of Blood Pressure (AMBP) to the Detection of Hypertension in Type 2 Diabetic Black African

Daniel Amoussou-Guenou^1,2*, Armand Wanvoegbe^1,3, Anthelme Agbodande², Alihonou Dansou³, Yessoufou Tchabi², Yasmine Eyisse², Arnaulde Amoussou-Guenou Fandi⁴, Latif Mousse²

¹Banque d’insuline, Cotonou, Benin.
²Polyclinique Atinkanmey, Cotonou, Benin.
³CHUD-OP, Porto-Novo, Benin.
⁴Clinique d’Akpakpa, Cotonou, Benin.

DOI: 10.4236/jdm.2015.53017                

Abstract

This paper is to determine the contribution of the ambulatory measure of blood pressure (AMBP) to the detection of hypertension in type 2 diabetic black African in Benin. Hypertension can stay unknown in diabetic patients. Patients and Methods: We conducted a cross-sectional, prospective, descriptive and analytical study at “Banqued’ insuline” of Cotonou, Polyclinique Atinkanmey and CHUD-Ouémé-Plateau. The study took place over a period of 6 months from March 01 to August 30 2014. The study included patients with type 1 or 2 diabetes who agreed to participate in the study and who made ambulatory measure of blood pressure (AMBP). Statistical analysis was done by using the software Excel 2013 and SPSS versus 18.0. Results: Sixty six patients were included. Forty one (62.1%) among them were female; sex-ratio was 0.61. The mean of age was 48.9 ± 8.8 years with range from 30 to 68 years. The prevalence of masked hypertension in type 2 diabetics was 37.9% (25/66). Abdominal obesity was the significative factor related to masked high blood pressure (HBP) in the type 2 diabetics (p = 0.005). Among diabetic with masked hypertension, 14 (56%) had “no dipper” profile and 11 (44%) had “dipper” profile. Conclusion: The ambulatory measure of blood pressure (AMBP) may take an important place in the detection of Hypertension in black type 2 diabetic subjects.

Keywords

Diabetes Mellitus, Masked Hypertension, AMBP

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Racine, N. (2003) High Blood Pressure in Diabetic Patients: How to Evaluate and Treat? Le Clinicien, 95-102.
[2]	Campbell, N.R.C., Gilbert, R.E., Leiter, L.A., et al. (2011) Hypertension in Patients with Type 2 Diabetes. Update on Pharmacological Treatment. Canadian Family Physician, 57, e347-e53.
[3]	Ben-Hamouda-Chihaoui, M., Kanoun, F., Ftouhi, B., et al. (2011) Evaluation of Blood Pressure Control by Ambulatory Blood Pressure Monitoring and Study of Factors Associated with Poor Blood Pressure Control in 300 Treated Hypertensive Type 2 Diabetic Patients. Annales De Cardiologie Et D Angeiologie, 60, 71-76.
[4]	Faouzi, K., Nefissa, B.A., Salma, I., et al. (2010) Appreciation of the BP Profile by Ambulatory Measure of Blood Pressure in Hypertensive Diabetics Treated. La Tunisie Médicale, 88, 885-889.
[5]	Hernandez, A., Rodriguez, E.G., Ballan, B.K., et al. (2012) The AMBP: Extension of the Physical Examination Done Well? Revue Médicale Suisse, 8, 1702-1708.
[6]	Working Group for the Management of Hypertension of the European Society of Hypertension (ESH) and European Society of Cardiology (ESC) (2007) Recommendations ESH 2007 for the Treatment of High Blood Pressure. Journal of Hypertension, 25, 1105-1187.
[7]	Vaisse, B. (2006) Masked Hypertension. Réalités cardiologiques, 1, 1-4.
[8]	Tanguy, B and Aboyans, V. (2012) The Management of Hypertensive Diabetic Patients. Revues Générales Diabétologie, 49-53.
[9]	Bobrie, G., Chatellier, G., Genes, N., et al. (2004) Cardiovascular Prognosis of “Masked Hypertension” Detected by Blood Pressure Self-Measurement in Elderly Treated Hypertensive Patients. Journal of the American Medical Association, 291, 1342-1349. http://dx.doi.org/10.1001/jama.291.11.1342
[10]	Palatini, P., Winnicki, M., Santonastaso, M., et al. (2004) Prevalence and Clinical Significance of Isolated Ambulatory Hypertension in Young Subjects Screened for Stage 1 Hypertension. Hypertension, 44, 170-174. http://dx.doi.org/10.1161/01.HYP.0000135250.57004.19
[11]	Ohkubo, T., Kikuya, M., Metoki, H., et al. (2005) Prognosis of “Masked” Hypertension and “White-Coat” Hypertension Detected by 24-h Ambulatory Blood Pressure Monitoring. 10-Year Follow-Up from the Ohasama Study. Journal of the American College of Cardiology, 46, 508-515. http://dx.doi.org/10.1016/j.jacc.2005.03.070
[12]	Bangalore, S., Kumar, S., Lobach, I., et al. (2011) Blood Pressure Targets in Subjects with Type 2 Diabetes Mellitus/ Impaired Fasting Glucose: Observations from Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials. Circulation, 123, 799-810. http://dx.doi.org/10.1161/circulationaha.110.016337
[13]	Heggie, A.J., Adamson, K.A., Marioni, R.E., et al. (2008) Is Non-Dipping of Nocturnal Blood Pressure in Type 2 Diabetes Associated With Increased Incidence of Microalbuminuria? British Journal of Diabetes and Vascular Disease, 8, 136-139.
[14]	Korkmaz, S., Yilmaz, A., Yildiz, G., et al. (2012) Relationship between Homocysteine and Non-Dipper Pattern in Patients with Type 2 Diabetes Mellitus. Arquivos Brasileiros de Endocrinologia . Metabologia, 56, 285-290.